838 related articles for article (PubMed ID: 25814625)
1. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.
Tandon A; Villa CR; Hor KN; Jefferies JL; Gao Z; Towbin JA; Wong BL; Mazur W; Fleck RJ; Sticka JJ; Benson DW; Taylor MD
J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25814625
[TBL] [Abstract][Full Text] [Related]
2. Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study.
Aikawa T; Takeda A; Oyama-Manabe N; Naya M; Yamazawa H; Koyanagawa K; Ito YM; Anzai T
Pediatr Cardiol; 2019 Feb; 40(2):384-392. PubMed ID: 30564867
[TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.
Hor KN; Taylor MD; Al-Khalidi HR; Cripe LH; Raman SV; Jefferies JL; O'Donnell R; Benson DW; Mazur W
J Cardiovasc Magn Reson; 2013 Dec; 15(1):107. PubMed ID: 24359596
[TBL] [Abstract][Full Text] [Related]
5. Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.
Lang SM; Shugh S; Mazur W; Sticka JJ; Rattan MS; Jefferies JL; Taylor MD
Pediatr Cardiol; 2015 Oct; 36(7):1495-501. PubMed ID: 25976773
[TBL] [Abstract][Full Text] [Related]
6. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy.
Henson SE; Lang SM; Khoury PR; Tian C; Rutter MM; Urbina EM; Ryan TD; Taylor MD; Alsaied T
J Am Heart Assoc; 2021 Oct; 10(19):e021037. PubMed ID: 34569261
[TBL] [Abstract][Full Text] [Related]
8. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
[TBL] [Abstract][Full Text] [Related]
9. Steroid therapy and cardiac function in Duchenne muscular dystrophy.
Markham LW; Spicer RL; Khoury PR; Wong BL; Mathews KD; Cripe LH
Pediatr Cardiol; 2005; 26(6):768-71. PubMed ID: 15990951
[TBL] [Abstract][Full Text] [Related]
10. Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.
Silva MC; Magalhães TA; Meira ZM; Rassi CH; Andrade AC; Gutierrez PS; Azevedo CF; Gurgel-Giannetti J; Vainzof M; Zatz M; Kalil-Filho R; Rochitte CE
JAMA Cardiol; 2017 Feb; 2(2):190-199. PubMed ID: 27926769
[TBL] [Abstract][Full Text] [Related]
11. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?
Puchalski MD; Williams RV; Askovich B; Sower CT; Hor KH; Su JT; Pack N; Dibella E; Gottliebson WM
Int J Cardiovasc Imaging; 2009 Jan; 25(1):57-63. PubMed ID: 18686011
[TBL] [Abstract][Full Text] [Related]
12. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.
Olivieri LJ; Kellman P; McCarter RJ; Cross RR; Hansen MS; Spurney CF
J Cardiovasc Magn Reson; 2016 Oct; 18(1):72. PubMed ID: 27788681
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular dysfunction in Duchenne muscular dystrophy.
James KA; Gralla J; Ridall LA; Do TN; Czaja AS; Mourani PM; Ciafaloni E; Cunniff C; Donnelly J; Oleszek J; Pandya S; Price E; Yang ML; Auerbach SR
Cardiol Young; 2020 Feb; 30(2):171-176. PubMed ID: 31964455
[TBL] [Abstract][Full Text] [Related]
14. Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance study.
Walcher T; Steinbach P; Spiess J; Kunze M; Gradinger R; Walcher D; Bernhardt P
Eur J Radiol; 2011 Oct; 80(1):115-9. PubMed ID: 20685051
[TBL] [Abstract][Full Text] [Related]
15. Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy.
Buddhe S; Lewin M; Olson A; Ferguson M; Soriano BD
Pediatr Radiol; 2016 Sep; 46(10):1399-408. PubMed ID: 27173979
[TBL] [Abstract][Full Text] [Related]
16. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
[TBL] [Abstract][Full Text] [Related]
17. Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.
Starc JJ; Moore RA; Rattan MS; Villa CR; Gao Z; Mazur W; Jefferies JL; Taylor MD
Pediatr Cardiol; 2017 Oct; 38(7):1485-1492. PubMed ID: 28762167
[TBL] [Abstract][Full Text] [Related]
18. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
Mavrogeni S; Papavasiliou A; Douskou M; Kolovou G; Papadopoulou E; Cokkinos DV
Eur J Paediatr Neurol; 2009 Jan; 13(1):34-40. PubMed ID: 18406648
[TBL] [Abstract][Full Text] [Related]
19. The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy Cardiomyopathy.
Soslow JH; Xu M; Slaughter JC; Crum K; Chew JD; Burnette WB; Su YR; Tomasek K; Parra DA; Markham LW
J Card Fail; 2019 Apr; 25(4):259-267. PubMed ID: 30763738
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular deformation and myocardial fibrosis in pediatric patients with Duchenne muscular dystrophy.
Kerstens TP; van Everdingen WM; Habets J; van Dijk APJ; Helbing WA; Thijssen DHJ; Udink Ten Cate FEA
Int J Cardiol; 2023 Oct; 388():131162. PubMed ID: 37433407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
